ABCELLERA BIOLOGICS INC (ABCL) — institutional ownership
144 funds reported holding ABCELLERA BIOLOGICS INC in their latest 13F filings, worth $1.01B in total (CUSIP 00288U106).
Largest holders
- BAKER BROS. ADVISORS LP — $259M
- TD Waterhouse Canada Inc. — $128M
- Capital World Investors — $107M
- TWO SIGMA INVESTMENTS, LP — $81.9M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $48.2M
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — $33.9M
- ArrowMark Colorado Holdings LLC — $32.2M
- BlackRock, Inc. (BLK) — $29.9M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $24.5M
- DRIEHAUS CAPITAL MANAGEMENT LLC — $22.5M
Famous investors holding it
- Two Sigma portfolio (Two Sigma Investments)
- Ken Griffin portfolio (Citadel Advisors)
- Renaissance Technologies portfolio (Renaissance Technologies)
- Izzy Englander portfolio (Millennium Management)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
Insider buying and selling at ABCELLERA BIOLOGICS INC
Who owns the most ABCL stock?
The largest institutional holders in the latest 13F filings are BAKER BROS. ADVISORS LP ($259M), TD Waterhouse Canada Inc. ($128M), Capital World Investors ($107M).
How many funds own ABCL?
144 funds reported holding it, worth $1.01B in total.